Quality of life and brain tumors

What beyond the clinical burden?

Anna Rita Giovagnoli, Rute Flávia Meneses, Antonio Silvani, Ida Milanesi, Laura Fariselli, Andrea Salmaggi, Amerigo Boiardi

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

This study analyzed the subjective facets of quality of life (QoL) and their relation to the type of brain tumor (BT) and phase of disease. Two hundred and ninety-one patients with pinealoblastoma, medulloblastoma, low-grade glioma, anaplastic astrocytoma, or glioblastoma were evaluated. With respect to 110 healthy controls, patients in the phases of radiotherapy/chemotherapy, stable disease, or tumor recurrence were significantly more anxious and depressed compared with patients in the early postoperative period. All patients were impaired in mental flexibility and memory, with preservation of abstract reasoning. The Functional Living Index-Cancer (FLIC), previously validated in cancer and BT patients, yielded six subjective factors (disease perception, affective well-being, role and leisure, personal base, nausea, sharing). None of the FLIC factors were predicted by tumor type, which only related to the physical and cognitive performances and mood scores. Affective well-being, role and leisure, and sharing were predicted by the phase of disease. Personal base, including self-perception and confidence, was independent on tumor progression and treatment. To conclude, QoL encompasses different subjective aspects, which vary in relation to the phase of disease and clinical burden. However, some person-related facets appear independent on tumor progression and treatment, indicating individual resources. Knowing this may guide tailored interventions supporting QoL.

Original languageEnglish
Pages (from-to)894-904
Number of pages11
JournalJournal of Neurology
Volume261
Issue number5
DOIs
Publication statusPublished - 2014

Fingerprint

Brain Neoplasms
Quality of Life
Neoplasms
Leisure Activities
Medulloblastoma
Astrocytoma
Glioblastoma
Postoperative Period
Self Concept
Glioma
Nausea
Radiotherapy
Recurrence
Drug Therapy
Therapeutics

Keywords

  • Brain tumor
  • Cognition
  • Mood
  • Physical performance
  • Quality of life

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology
  • Medicine(all)

Cite this

Quality of life and brain tumors : What beyond the clinical burden? / Giovagnoli, Anna Rita; Meneses, Rute Flávia; Silvani, Antonio; Milanesi, Ida; Fariselli, Laura; Salmaggi, Andrea; Boiardi, Amerigo.

In: Journal of Neurology, Vol. 261, No. 5, 2014, p. 894-904.

Research output: Contribution to journalArticle

Giovagnoli, Anna Rita ; Meneses, Rute Flávia ; Silvani, Antonio ; Milanesi, Ida ; Fariselli, Laura ; Salmaggi, Andrea ; Boiardi, Amerigo. / Quality of life and brain tumors : What beyond the clinical burden?. In: Journal of Neurology. 2014 ; Vol. 261, No. 5. pp. 894-904.
@article{959d4265f44845ab8e988680094e9fcb,
title = "Quality of life and brain tumors: What beyond the clinical burden?",
abstract = "This study analyzed the subjective facets of quality of life (QoL) and their relation to the type of brain tumor (BT) and phase of disease. Two hundred and ninety-one patients with pinealoblastoma, medulloblastoma, low-grade glioma, anaplastic astrocytoma, or glioblastoma were evaluated. With respect to 110 healthy controls, patients in the phases of radiotherapy/chemotherapy, stable disease, or tumor recurrence were significantly more anxious and depressed compared with patients in the early postoperative period. All patients were impaired in mental flexibility and memory, with preservation of abstract reasoning. The Functional Living Index-Cancer (FLIC), previously validated in cancer and BT patients, yielded six subjective factors (disease perception, affective well-being, role and leisure, personal base, nausea, sharing). None of the FLIC factors were predicted by tumor type, which only related to the physical and cognitive performances and mood scores. Affective well-being, role and leisure, and sharing were predicted by the phase of disease. Personal base, including self-perception and confidence, was independent on tumor progression and treatment. To conclude, QoL encompasses different subjective aspects, which vary in relation to the phase of disease and clinical burden. However, some person-related facets appear independent on tumor progression and treatment, indicating individual resources. Knowing this may guide tailored interventions supporting QoL.",
keywords = "Brain tumor, Cognition, Mood, Physical performance, Quality of life",
author = "Giovagnoli, {Anna Rita} and Meneses, {Rute Fl{\'a}via} and Antonio Silvani and Ida Milanesi and Laura Fariselli and Andrea Salmaggi and Amerigo Boiardi",
year = "2014",
doi = "10.1007/s00415-014-7273-3",
language = "English",
volume = "261",
pages = "894--904",
journal = "Journal of Neurology",
issn = "0340-5354",
publisher = "Dr. Dietrich Steinkopff Verlag GmbH and Co. KG",
number = "5",

}

TY - JOUR

T1 - Quality of life and brain tumors

T2 - What beyond the clinical burden?

AU - Giovagnoli, Anna Rita

AU - Meneses, Rute Flávia

AU - Silvani, Antonio

AU - Milanesi, Ida

AU - Fariselli, Laura

AU - Salmaggi, Andrea

AU - Boiardi, Amerigo

PY - 2014

Y1 - 2014

N2 - This study analyzed the subjective facets of quality of life (QoL) and their relation to the type of brain tumor (BT) and phase of disease. Two hundred and ninety-one patients with pinealoblastoma, medulloblastoma, low-grade glioma, anaplastic astrocytoma, or glioblastoma were evaluated. With respect to 110 healthy controls, patients in the phases of radiotherapy/chemotherapy, stable disease, or tumor recurrence were significantly more anxious and depressed compared with patients in the early postoperative period. All patients were impaired in mental flexibility and memory, with preservation of abstract reasoning. The Functional Living Index-Cancer (FLIC), previously validated in cancer and BT patients, yielded six subjective factors (disease perception, affective well-being, role and leisure, personal base, nausea, sharing). None of the FLIC factors were predicted by tumor type, which only related to the physical and cognitive performances and mood scores. Affective well-being, role and leisure, and sharing were predicted by the phase of disease. Personal base, including self-perception and confidence, was independent on tumor progression and treatment. To conclude, QoL encompasses different subjective aspects, which vary in relation to the phase of disease and clinical burden. However, some person-related facets appear independent on tumor progression and treatment, indicating individual resources. Knowing this may guide tailored interventions supporting QoL.

AB - This study analyzed the subjective facets of quality of life (QoL) and their relation to the type of brain tumor (BT) and phase of disease. Two hundred and ninety-one patients with pinealoblastoma, medulloblastoma, low-grade glioma, anaplastic astrocytoma, or glioblastoma were evaluated. With respect to 110 healthy controls, patients in the phases of radiotherapy/chemotherapy, stable disease, or tumor recurrence were significantly more anxious and depressed compared with patients in the early postoperative period. All patients were impaired in mental flexibility and memory, with preservation of abstract reasoning. The Functional Living Index-Cancer (FLIC), previously validated in cancer and BT patients, yielded six subjective factors (disease perception, affective well-being, role and leisure, personal base, nausea, sharing). None of the FLIC factors were predicted by tumor type, which only related to the physical and cognitive performances and mood scores. Affective well-being, role and leisure, and sharing were predicted by the phase of disease. Personal base, including self-perception and confidence, was independent on tumor progression and treatment. To conclude, QoL encompasses different subjective aspects, which vary in relation to the phase of disease and clinical burden. However, some person-related facets appear independent on tumor progression and treatment, indicating individual resources. Knowing this may guide tailored interventions supporting QoL.

KW - Brain tumor

KW - Cognition

KW - Mood

KW - Physical performance

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=84901935081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901935081&partnerID=8YFLogxK

U2 - 10.1007/s00415-014-7273-3

DO - 10.1007/s00415-014-7273-3

M3 - Article

VL - 261

SP - 894

EP - 904

JO - Journal of Neurology

JF - Journal of Neurology

SN - 0340-5354

IS - 5

ER -